Company Profiles

driven by the PitchBook Platform

Algentech

Description

Developer of technology to improve the genome of plant species. The company develops and commercializes plant gene editing technologies for industrial and research applications. Their processes help in gene targeting and chloroplast transformation in plants.

2009

Founded

PRIVATE

Status

Early Stage VC

Latest Deal Type

1

Investors

Description

Developer of technology to improve the genome of plant species. The company develops and commercializes plant gene editing technologies for industrial and research applications. Their processes help in gene targeting and chloroplast transformation in plants.

Website:

www.algentech.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

4 Rue Pierre Fontaine 91058 Évry CedexFrance
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Algentech's full profile, request a free trial.

    Algentech Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Algentech Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Scientipole CapitalVenture CapitalMinority000 0000000 0000
    Scientipole Capital Venture Capital

    Algentech Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Alexander SorokinCo-Founder, Chief Executive Officer & President
    Isabelle Malcuit Ph.DCo-Founder, Chief Scientific Officer & Director
    Alexander Sorokin Co-Founder, Chief Executive Officer & President
    Isabelle Malcuit Ph.D Co-Founder, Chief Scientific Officer & Director
    Request full access to PitchBook